Sofinnova Investments Inc. Buys Shares of 46,201 Masimo Corporation $MASI

Sofinnova Investments Inc. bought a new stake in Masimo Corporation (NASDAQ:MASI) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 46,201 shares of the medical equipment provider’s stock, valued at approximately $6,009,000. Sofinnova Investments Inc. owned about 0.09% of Masimo as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of MASI. Royal Bank of Canada lifted its position in shares of Masimo by 44.5% in the 1st quarter. Royal Bank of Canada now owns 43,884 shares of the medical equipment provider’s stock worth $7,311,000 after acquiring an additional 13,513 shares during the period. AQR Capital Management LLC increased its holdings in Masimo by 136.5% during the 1st quarter. AQR Capital Management LLC now owns 8,142 shares of the medical equipment provider’s stock valued at $1,305,000 after purchasing an additional 4,700 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Masimo by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock valued at $1,894,000 after buying an additional 66 shares during the period. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Masimo in the 1st quarter valued at $220,000. Finally, Jones Financial Companies Lllp increased its stake in shares of Masimo by 1,267.1% in the 1st quarter. Jones Financial Companies Lllp now owns 2,201 shares of the medical equipment provider’s stock valued at $367,000 after buying an additional 2,040 shares during the period. Institutional investors own 85.96% of the company’s stock.

Masimo Price Performance

Masimo stock opened at $179.95 on Tuesday. Masimo Corporation has a 12 month low of $125.94 and a 12 month high of $179.99. The stock’s 50 day moving average is $178.72 and its 200-day moving average is $160.89. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56. The company has a market capitalization of $9.42 billion, a price-to-earnings ratio of -17.07, a PEG ratio of 1.82 and a beta of 1.11.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on MASI. Piper Sandler cut Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price objective for the company. in a research note on Tuesday, February 17th. Stifel Nicolaus set a $180.00 target price on Masimo in a report on Tuesday, February 17th. Weiss Ratings upgraded Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. BTIG Research lowered Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Finally, Wolfe Research lowered Masimo from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 19th. Nine analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $180.40.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.